Application 218441
- Type
- ANDA
- Sponsor
- BIOCON PHARMA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | SITAGLIPTIN | SITAGLIPTIN | TABLET | 50MG | No | No |
| 003 | SITAGLIPTIN | SITAGLIPTIN | TABLET | 100MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| JANUVIA | SITAGLIPTIN | A-S Medication Solutions | 62c4f58b-2b28-4825-aeb6-213ab9b7a026 | 2026-07-08 | Warnings, Adverse reactions | SITAGLIPTIN |
| JANUVIA | SITAGLIPTIN | A-S Medication Solutions | 194c3718-5eb5-4cf5-85d0-2bb1ed8293b8 | 2026-07-08 | Warnings, Adverse reactions | SITAGLIPTIN |
| JANUVIA | SITAGLIPTIN | A-S Medication Solutions | 4a758211-8af1-449b-9a10-f3d67d7ec8b6 | 2026-07-08 | Warnings, Adverse reactions | SITAGLIPTIN |
| JANUVIA | SITAGLIPTIN | A-S Medication Solutions | 1b03c82f-b52e-4092-b9dc-f2c9b0d6ab40 | 2026-07-08 | Warnings, Adverse reactions | SITAGLIPTIN |
| JANUVIA | SITAGLIPTIN | A-S Medication Solutions | eb81a45f-05b8-49de-99ce-5089bd360d9b | 2026-07-08 | Warnings, Adverse reactions | SITAGLIPTIN |
| Sitagliptin | SITAGLIPTIN | Apotex Corp. | 983e9e14-e9bd-3136-e573-98b4dc67860b | 2026-04-14 | Warnings, Adverse reactions | Sitagliptin SITAGLIPTIN |
| Sitagliptin | SITAGLIPTIN | Teva Pharmaceuticals, Inc. | 5fa5aa67-455e-4ac6-864d-268a91286432 | 2025-12-01 | Warnings, Adverse reactions | Sitagliptin SITAGLIPTIN |
| JANUVIA | SITAGLIPTIN | Cardinal Health 107, LLC | 9d558f96-24a5-4788-8933-38256c17384b | 2025-11-05 | Warnings, Adverse reactions | SITAGLIPTIN |
| JANUVIA | SITAGLIPTIN | Cardinal Health 107, LLC | 39253ddd-0245-43b1-ad28-d5923983afb4 | 2025-11-05 | Warnings, Adverse reactions | SITAGLIPTIN |
| ZITUVIO | SITAGLIPTIN | Zydus Pharmaceuticals (USA) Inc. | abfdea45-c0ca-41e3-a510-e89810bc9cfe | 2025-01-31 | Warnings, Adverse reactions | SITAGLIPTIN |
| ZITUVIO | SITAGLIPTIN | Zydus Lifesciences Limited | b2da9d77-154b-48f7-8793-3f4a24dfafc6 | 2025-01-31 | Warnings, Adverse reactions | SITAGLIPTIN |
| Sitagliptin | SITAGLIPTIN | Zydus Pharmaceuticals (USA) Inc. | 6a970e80-b753-48fa-9fff-87e7a5044982 | 2025-01-31 | Warnings, Adverse reactions | Sitagliptin SITAGLIPTIN |
| Sitagliptin | SITAGLIPTIN | Zydus Lifesciences Limited | e5ac97e8-3a0b-4750-8e3f-337412570746 | 2025-01-31 | Warnings, Adverse reactions | Sitagliptin SITAGLIPTIN |
| JANUVIA | SITAGLIPTIN | Merck Sharp & Dohme LLC | f85a48d0-0407-4c50-b0fa-7673a160bf01 | 2024-11-14 | Warnings, Adverse reactions | SITAGLIPTIN |
| JANUVIA | SITAGLIPTIN | A-S Medication Solutions | e2e576e6-6181-4178-b989-61d0e795e559 | 2024-01-31 | Warnings, Adverse reactions | SITAGLIPTIN |